
Academic Pharmaceuticals Inc Profile last edited on: 11/20/19
CAGE: 4BPH3
UEI: ZC8ZATDAATL9
Business Identifier: Cardiovascular products Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
21 Skokie Valley Road Suite G3
Lake Bluff, IL 60044
Lake Bluff, IL 60044
(847) 735-1170 |
N/A |
N/A |
Location: Single
Congr. District: 10
County: Lake
Congr. District: 10
County: Lake
Public Profile
Specializing in cardiovascular products, Academic Pharmaceuticals Inc is an R&D firm developing anti-arrhythmic parenteral compounds and other cardiovascular drugs needed by practicing cardiologists or emergency room physicians. Many of the products in development are orphan drugs that serve specialized populations. The company's expertise is in solubilization of insoluble compounds and designing expedited clinical development and regulatory review programs.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2019 | 1 | NIH | $158,460 | |
Project Title: Developing a Parenteral Formulation of Metolazone | ||||
2019 | 1 | NIH | $153,260 | |
Project Title: Soestolol: a Potentially Short Acting Type III Anti-Arrhythmic | ||||
2017 | 1 | NIH | $149,980 | |
Project Title: A Safer Cardiac, Abuse Deterrent Formulation of Methadone | ||||
2010 | 1 | NIH | $102,910 | |
Project Title: Reducing Methadone's Arrhythmic Potential | ||||
2009 | 1 | NIH | $100,188 | |
Project Title: Pediatric Acceptable Formulation Of Amiodarone |
Key People / Management
John C Somberg -- President
Janos Molnar -- Director of Clinical Research
Janos Molnar -- Director of Clinical Research
Company News
There are no news available.